These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4705677)

  • 1. Excretion of trans- 9 -tetrahydrocannabinol and its metabolites in intact and bile duct-cannulated rats.
    Turk RF; Dewey WL; Harris LS
    J Pharm Sci; 1973 May; 62(5):737-40. PubMed ID: 4705677
    [No Abstract]   [Full Text] [Related]  

  • 2. Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat.
    Widman M; Nordqvist M; Agurell S; Lindgren JE; Sandberg F
    Biochem Pharmacol; 1974 Apr; 23(7):1163-72. PubMed ID: 4823449
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of (-)-delta 9-6a,10a-trans-tetrahydrocannabinol and two of its metabolites in rats by use of combination gas chromatography-mass spectrometry and mass fragmentography.
    Mikes F; Hofmann A; Waser PG
    Biochem Pharmacol; 1971 Sep; 20(9):2469-76. PubMed ID: 4355783
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of delta1-tetrahydrocannabinol by rats tolerant to cannabis.
    Siemens AJ; Kalant H
    Can J Physiol Pharmacol; 1974 Dec; 52(6):1154-66. PubMed ID: 4451887
    [No Abstract]   [Full Text] [Related]  

  • 5. The distribution and excretion of tetrahydrocannabinol-C 14 in humans.
    Miras C; Coutselinis A
    Med Sci Law; 1971 Oct; 11(4):197-9. PubMed ID: 5148725
    [No Abstract]   [Full Text] [Related]  

  • 6. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.
    Lemberger L; Crabtree RE; Rowe HM
    Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of the disposition of 14C-delta 9-tetrahydrocannabinol and 3H-delta 9-tetrahydrocannabinol.
    Siemens AJ; Doyle OL; Pryor GT
    Life Sci; 1979 Apr; 24(14):1261-74. PubMed ID: 470542
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution studies of (14C)delta-9-tetrahydrocannabinol in mice: effect of vehicle, route of administration, and duration of treatment.
    Mantilla-Plata B; Harbison RD
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):292-300. PubMed ID: 1209626
    [No Abstract]   [Full Text] [Related]  

  • 9. Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinol.
    McCallum ND; Yagen B; Levy S; Mechoulam R
    Experientia; 1975 May; 31(5):520-1. PubMed ID: 1140243
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of delta-1-tetrahydrocannabinol by the rat in vivo and in vitro.
    Siemens AJ; Kalant H
    Biochem Pharmacol; 1975 Apr; 24(7):755-62. PubMed ID: 235932
    [No Abstract]   [Full Text] [Related]  

  • 11. Delta9-tetrahydrocannabinol-uptake by rat liver lysosomes.
    Irvin JE; Mellors A
    Biochem Pharmacol; 1975 Jan; 24(2):305-7. PubMed ID: 1111544
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism and distribution of cannabinoids in rats after different methods of administration.
    Leighty EG
    Biochem Pharmacol; 1973 Jul; 22(13):1613-21. PubMed ID: 4729809
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.
    Garrett ER; Hunt CA
    J Pharm Sci; 1977 Mar; 66(3):395-407. PubMed ID: 845807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of delta1-tetrahydrocannabinol and 7-hydroxy-delta-tetrahydrocannabinol in the mouse brain after intraventricular injection.
    Gill EW; Lawrence DK
    J Pharm Pharmacol; 1973 Dec; 25(12):948-52. PubMed ID: 4150297
    [No Abstract]   [Full Text] [Related]  

  • 15. Distribution and metabolism in vivo of 14C-tetrahydrocannabinol in the rat.
    Willinsky MD; Kalant H; Meresz O; Endrenyi L; Woo N
    Eur J Pharmacol; 1974 Jun; 27(1):106-19. PubMed ID: 4851409
    [No Abstract]   [Full Text] [Related]  

  • 16. Fate of 14C-delta1-THC in rat plasma after intravenous injection and smoking.
    Fehr KO; Kalant H
    Eur J Pharmacol; 1974 Jan; 25(1):1-8. PubMed ID: 4435008
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic fate of [3H]-l-menthol in the rat.
    Yamaguchi T; Caldwell J; Farmer PB
    Drug Metab Dispos; 1994; 22(4):616-24. PubMed ID: 7956738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced bioavailability of a new thiazolidine derivative FPFS-410, an antidiabetic and lipid-lowering drug, after oral administration of its hydroxypropyl-beta-cyclodextrin complex to bile duct-cannulated rats.
    Hara T; Arima H; Hirayama F; Uekama K
    J Pharm Sci; 2006 Aug; 95(8):1771-82. PubMed ID: 16795019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 20. The metabolism of the tetrahydrocannabinols.
    Lemberger L
    Adv Pharmacol Chemother; 1972; 10():221-55. PubMed ID: 4598605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.